Accelerated Pharma Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • IPO
  • (Postponed)
  • Latest Deal Amount
  • $3M
Latest Deal Amount
  • Investors
  • 1

Accelerated Pharma General Information

Description

Operator of biotechnology company intended to develop cancer drugs. The company focused on in-licensing late-stage drug programs for ovarian, colorectal and small cell lung cancer patients, enabling patients to recover cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 15 West 155, 81st Street
  • Burr Ridge, IL 60527
  • United States
+1 (847) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Accelerated Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. IPO 22-Oct-2018 $3M 000.00 Postponed Clinical Trials - General
3. IPO 23-Aug-2017 00.00 000.00 Cancelled Startup
2. Convertible Debt 04-May-2016 $250K $3.55M Completed Startup
1. Angel (individual) 18-Nov-2015 $3.3M $3.3M Completed Startup
To view Accelerated Pharma’s complete valuation and funding history, request access »

Accelerated Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of biotechnology company intended to develop cancer drugs. The company focused on in-licensing late-stage drug
Biotechnology
Burr Ridge, IL
6 As of 2019
00.000
00.00 0000-00-00
00000000

00 00000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m
0000000000000
Durham, NC
000 As of 0000
00000
000000 - 000 00000

000 0000

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Accelerated Pharma Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
G1 Therapeutics Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
000 000000000000 Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
00000000 Venture Capital-Backed New York, NY 00 0000 00000000000 0000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
0000000 000000 Venture Capital-Backed Stockholm, Sweden 0 000.00 0000000000 0 000.00
You’re viewing 5 of 11 competitors. Get the full list »

Accelerated Pharma Patents

Accelerated Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110033528-A1 Stabilized picoplatin oral dosage form Abandoned 05-Aug-2009 00000000 00
US-20150196494-A1 Stabilized picoplatin oral dosage form Abandoned 05-Aug-2009 00000000
US-20130183433-A1 Stabilized picoplatin oral dosage form Abandoned 09-Feb-2007 00000000
US-8173686-B2 Use of picoplatin to treat colorectal cancer Expired - Fee Related 06-Nov-2006 0000000000 0
US-8168661-B2 Use of picoplatin to treat colorectal cancer Expired - Fee Related 06-Nov-2006 A61K31/282

Accelerated Pharma Executive Team (5)

Name Title Board Seat Contact Info
Teddy Scott Ph.D Co-Founder, Secretary & Executive Officer
Randy Saluck Chief Financial & Strategic Officer
Ekaterina Nikolaevskaya Chief Operating Officer & Board Member
Michael Kurman MD Chief Clinical Advisor
Dmitry Prudnikov MD Chief Medical Officer & Board Member
To view Accelerated Pharma’s complete executive team members history, request access »

Accelerated Pharma Board Members (7)

Name Representing Role Since
Daniel Perez Accelerated Pharma Board Member 000 0000
Dmitry Prudnikov MD Accelerated Pharma Chief Medical Officer & Board Member 000 0000
Douglas Watson Accelerated Pharma Board Member 000 0000
Ekaterina Nikolaevskaya Accelerated Pharma Chief Operating Officer & Board Member 000 0000
Michael Fonstein Ph.D Accelerated Pharma President, Board Member & Chief Executive Officer 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Accelerated Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accelerated Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alpha Capital Anstalt Corporation Minority 000 0000 000000 0
To view Accelerated Pharma’s complete investors history, request access »